Lenacapavir could transform HIV prevention, but patent licensing decisions will determine who actually gets access.
Many countries are excluded despite high HIV burdens
For more explore our latest blog by @PatentsInHumans ⬇️
🔗 tinyurl.com/u8bjxb6n
Many countries are excluded despite high HIV burdens
For more explore our latest blog by @PatentsInHumans ⬇️
🔗 tinyurl.com/u8bjxb6n